Pfizer, BioNTech, Moderna, Johnson & Johnson, Novavax: Which COVID vaccine stock is the best pick for investors seeking strong growth? What about those looking for income? And how about value investors? The author of today’s article assesses which vaccine stock is best for which type of investor, depending on which factor is the most important to them. For more, CLICK…
With COVID-19 vaccine stocks Pfizer and Moderna receiving so much attention, the author of today’s article notes that “This leaves a lot of biotech stocks lacking the attention they deserve. While this is bad news for current holders of these stocks, it is an opportunity for new ones.” With this in mind, he proceeds to highlight three “under-loved” biotech stocks…
When it comes to the advantage that emerging coronavirus stocks have over their more established counterparts, the author of today’s article notes that, “While coronavirus vaccine companies such as Moderna, AstraZeneca, and Pfizer have market caps amounting to tens of billions of dollars, small- to mid-cap coronavirus stocks can potentially be multi-baggers, albeit with higher risks.” He proceeds to take…